Mimetogen Pharmaceuticals
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1000 De La Gauchetière Street West Ste 2...Phone Number
(617) 395-8580Website
www.mimetogen.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Mimetogen Pharmaceuticals
Mimetogen Pharmaceuticals is a late-stage clinical biotechnology company dedicated to developing synthetic neurotrophin mimetics for treating ocular surface diseases, particularly dry eye disease (DED). The company is advancing its lead compound, tavilermide, through Phase 3 clinical trials in the United States, aiming to address high unmet medical needs in ophthalmology. Mimetogen also explores therapeutic options for retinal degenerative diseases like retinitis pigmentosa. With a team of renowned experts and clinical collaborators, Mimetogen is committed to creating new treatments for eye diseases that currently have limited or no available therapies.Explore more
Mimetogen Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Mimetogen Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Mimetogen Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Mimetogen Pharmaceuticals recently announced quarterly report
Funding: Get notified immidiatlly once Mimetogen Pharmaceuticals has new funding data
Mimetogen Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Mimetogen Pharmaceuticals had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Mimetogen Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Mimetogen Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Mimetogen Pharmaceuticals
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Mimetogen Pharmaceuticals
Compare insights from companies similar to Mimetogen Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Mimetogen Pharmaceuticals
$5.3M
1-10
Private
-
2005
KM
Karen MeerovitchSenior Vice President and Chief Development Officer
Company Profile Activity
Activity Insights
Mimetogen Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Mimetogen Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Mimetogen Pharmaceuticals.
Mimetogen Pharmaceuticals News & Media
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Mimetogen Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Mimetogen Pharmaceuticals is a late-stage clinical biotechnology company dedicated to developing synthetic neurotrophin mimetics for treating ocular surface diseases, particularly dry eye disease (DED). The company is advancing its lead compound, tavilermide, through Phase 3 clinical trials in the United States, aiming to address high unmet medical... Read More
